NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 231 filers reported holding NEVRO CORP in Q4 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,633 | +257.2% | 189 | +372.5% | 0.00% | – |
| Q2 2023 | $1,017 | -74.2% | 40 | -63.3% | 0.00% | – |
| Q1 2023 | $3,941 | -17.1% | 109 | -9.2% | 0.00% | – |
| Q4 2022 | $4,752 | -32.1% | 120 | -21.1% | 0.00% | – |
| Q3 2022 | $7,000 | 0.0% | 152 | 0.0% | 0.00% | – |
| Q2 2022 | $7,000 | -12.5% | 152 | +38.2% | 0.00% | – |
| Q1 2022 | $8,000 | -27.3% | 110 | -18.5% | 0.00% | – |
| Q4 2021 | $11,000 | -35.3% | 135 | -10.6% | 0.00% | – |
| Q3 2021 | $17,000 | -48.5% | 151 | -24.5% | 0.00% | – |
| Q2 2021 | $33,000 | +26.9% | 200 | +11.7% | 0.00% | – |
| Q1 2021 | $26,000 | +8.3% | 179 | +28.8% | 0.00% | – |
| Q4 2020 | $24,000 | +26.3% | 139 | +5.3% | 0.00% | – |
| Q3 2020 | $19,000 | +18.8% | 132 | 0.0% | 0.00% | – |
| Q2 2020 | $16,000 | +33.3% | 132 | +12.8% | 0.00% | – |
| Q1 2020 | $12,000 | -14.3% | 117 | -1.7% | 0.00% | – |
| Q4 2019 | $14,000 | +27.3% | 119 | 0.0% | 0.00% | – |
| Q3 2019 | $11,000 | +450.0% | 119 | +340.7% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 27 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | +100.0% | 27 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | – | 27 | +440.0% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 5 | -61.5% | 0.00% | – |
| Q2 2018 | $1,000 | -99.6% | 13 | -99.5% | 0.00% | – |
| Q3 2017 | $238,000 | +25.3% | 2,627 | +3.4% | 0.00% | – |
| Q2 2017 | $190,000 | +2614.3% | 2,540 | +2753.9% | 0.00% | – |
| Q2 2016 | $7,000 | +40.0% | 89 | -4.3% | 0.00% | – |
| Q1 2016 | $5,000 | -16.7% | 93 | +3.3% | 0.00% | – |
| Q4 2015 | $6,000 | +50.0% | 90 | 0.0% | 0.00% | – |
| Q3 2015 | $4,000 | +100.0% | 90 | +95.7% | 0.00% | – |
| Q2 2015 | $2,000 | +100.0% | 46 | +76.9% | 0.00% | – |
| Q1 2015 | $1,000 | – | 26 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |